Bright Minds Biosciences Announces Closing of US$175 Million Public Offering
(CNSX:DRUG.CN),(CNSX:DRUG),(NASDAQ:DRUG), NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) — Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) (“Bright Minds” or the “Company“) today closed its recently announced public offering of 1,945,000 common shares in the capital of the Company (the “Common Shares“) at a price of US$90.00 per Common Share for gross proceeds of US$175,050,000 […]